| Literature DB >> 12041669 |
Abstract
A patient who received antithymocyte globulin therapy for aplastic anemia due to D-penicillamine therapy is described. Bone marrow recovery and peripheral blood recovery were complete 1 month and 3 months, respectively, after treatment, and blood transfusion or other therapies were not necessary in a follow-up period of more than 2 years. Use of antithymocyte globulin may be the optimal treatment of D-penicillamine-induced aplastic anemia.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12041669 DOI: 10.1007/bf02982129
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490